WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

A trial into the use of a modified bone cancer drug as a possible treatment for people with the autoimmune disorder Alopecia Areata, which leads to sudden, patchy hair loss, has been green-lit to continue by America’s Food and Drug Administration.

The FDA had caused some concern among investors in US company Concert Pharmaceuticals when it put a temporary halt on a trial into its variation on the JAK inhibitor drug ruxolitinib as a possible treatment for Alopecia Areata. Ruxolitinib is also known by its current brand names Jakafi or Jakavi; it is currently prescribed in oral form for conditions such as myelofibrosis. It is being explored as a topical drug for Alopecia Areata after clinical trials in the USA discovered the topical formulation to be potentially more effective than an oral tablet.

Less than two months after the FDA-sanctioned halt was called, Massachusetts-based Concert has amended the scope of the trial into its orally-administered CTP-543 drug and been allowed to proceed.

food-and-drug-administration-usa-fdaDesign of trial modified

Roger Tung, Concert’s CEO, said: ““We believe the FDA is taking a measured approach for the development of Janus kinases inhibitors, or JAK inhibitors, for autoimmune dermatological disorders, including alopecia areata. Accordingly, we agreed to modify the design of our Phase IIa trial to evaluate CTP-543 in the patient population in a more step-wise fashion.”

Specifically, Concert has agreed to test low doses of the drug – 4mg and 8mg twice daily, or a placebo – before they will consider whether it is safe to increase it. Adds Tung: ‘It is important to note that CTP-543 has been well-tolerated in clinical evaluation to date and demonstrates a non-clinical safety profile consistent with JAK inhibition.”

The company plans on using a group of around 100 volunteers with patchy hairloss caused by Alopecia Areata for the double-blind trial. Though ruxolitinib itself has shown a great deal of promise as a possible future treatment option for the condition during its numerous clinical trials to date, Concert’s deuterated ruxolitinib drug may have the potential to offer patients a less-frequent dose regimen. This is because it has been engineered to have a longer half life than regular ruxolitinib, or, simply put, it should remain in the bloodstream for longer.

Drugs need to be proven

Studies into possible new treatments for the autoimmune disorder – which affects at least two per cent of all people in their lifetime – are ongoing at multiple locations around the world, though as all drugs need to be proven to be both safe and effective before they are cleared/licensed by the regulatory bodies of whichever countries they are intended for sale, it is a necessarily slow business.

At Belgravia, Alopecia Areata treatment is currently offered in the form of topical applications of the drug high strength minoxidil which has been seen to often produce highly effective results in regrowing hair on the scalp. Minoxidil is licensed by the MHRA for use on pattern hair loss in men and women, though it has also resulted in many success stories when used to treat Alopecia Areata.


Circ - Minoxidil iconThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Cold cap devices which chill the scalp during cancer treatment in order to help reduce hair loss are to be offered to more and more patients in the US following a new government ruling.

The US Food and Drug Administration (FDA) has cleared a device named the DigniCap Cooling System for use on people with different types of cancer than those it is already cleared for.

The Dignicap Scalp Cooling SystemStudy on 122 women

Since 2015, DigniCap’s device has been cleared for use on patients with breast cancer following a study on 122 women with the disease who were undergoing chemotherapy. This study showed that two thirds of those who wore the device during treatment lost less than half of their hair.

In support of the expanded use of the device, DigniCap submitted evidence from published, peer-reviewed articles that analysed the application of the DigniCap to cancer patients with solid tumours in other areas of the body.

This data was deemed by the FDA to be sufficient scientific evidence to support the safety and efficacy of DigniCap for expanded use.

“We are pleased to expand the use of this product for cancer patients with solid tumours to potentially minimise chemotherapy-induced hair loss,” said Binita Ashar, M.D., director, Division of Surgical Devices, in the FDA’s Center for Devices and Radiological Health. “Managing the side effects of chemotherapy is a critical component to overall health and quality of life.”

Total baldness possible

The side effects she mentions do include hair loss in a great many cases, as drugs designed to treat tumours are often unable to detect between healthy cells and cancerous ones and can cause damage to hair follicles, which leads to thinning. This can range from patchy hair loss to rather more severe shedding and even total baldness.

The cold cap chills the scalp to an optimal temperature to significantly reduce the flow of blood around that region. As the circulation reduces locally, so too does the likelihood that the cancer drugs will wreak havoc with the hair follicles, preventing hair fall. It can be a huge boon to people undergoing chemotherapy treatment, as when people are already feeling especially vulnerable and often physically weakened by their exposure to cancer drugs, the highly visible sign of losing their hair can often feel like the ultimate slap in the face.

The downside of cold caps is that they can be rather uncomfortable to wear due to the low temperatures involved, though few people seem to find them unbearable. There’s also no guarantee that hairloss won’t happen. Trials by UK company Paxman, however, have shown them to be very effective, and their own device – the Paxman Scalp Cooling System – claims an 89 per cent success rate on breast cancer patients.

When hair is lost to cancer drugs it usually grows back in a matter of months, though it can take up to a year for a full head of hair to properly regrow. A strange quirk of chemotherapy treatment is that hair quite often grows back slightly differently to how it was before – once-light hair can return slightly darker, and curls where hair used to be straight are common, too. Fortunately, this is usually only temporary, lasting around a couple of hair growth cycles.


The Belgravia CentreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert alopecia areata ophaisic and alopecia areata belgravia centre 20 07 17A new entry has just been added to Belgravia’s Alopecia Areata Treatment Success Stories gallery. In this particular case, the condition is referred to as Ophiasic Alopecia Areata due to the pattern.

Ms Price, pictured, is very pleased to see lots of new growth in the affected areas.

Find out what she had to say and see her regrowth results close up, or find out more about treating Alopecia Areata by clicking the buttons below…

 

VIEW SUCCESS STORY

TreatmenT information 

 


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Share this article

A pharmaceutical company in the US has announced the results of a small UK trial into a new injection-based treatment for people with genetic hair loss.
Kerastem body fat scalp injectins hair loss treatment
Kerastem, whose website poses the question “What if your body had the power to grow your hair back?”, has been exploring the idea that modified body fat that is re-injected back into the scalp could encourage new hairs to grow. It has recruited around 70 people for a major study into possible new treatment options for male pattern baldness and female pattern hair loss which it has named the STYLE trial; the UK study appears to be something of a precursor to this.

Body fat solution injected into scalp

According to a press release from the company: “All six (100%) subjects receiving Kerastem Therapy had an increase from baseline hair counts at six months, with initial results as early as six weeks.”

The trial saw doctors perform single scalp injections of Kerastem Cell Therapy in nine healthy hair loss patients, of whom six were followed for a total of six months.

Those six volunteers saw a mean increase of 31 hairs per cm2 of scalp at 24 weeks, compared to baseline, which equated to an increase of 23 per cent. One or more of the subjects reportedly saw up to a 53 per cent increase – which naturally means that at least one other subject had a growth rate somewhat lower than 23 per cent as well. The individual results have not been released at this time.

Said lead investigator Dr David Perez-Meza: “We are very pleased with the clinical outcomes of our hair regeneration study, as they represent this procedure is safe and that results are on par or better than those of traditional medical approaches to hair loss.”

The STYLE trial proper is currently underway and Dr Eric Daniels, chief medical officer at Kerastem, says he looks forward to releasing top-line, 24-week data from it later this year. He added that: “Fat and fat derived cells are now appreciated as a dynamic and vital participant in the normal cycle of hair growth.”

His words echo those of proponents of a broadly similar treatment in which Platelet-Rich Plasma (PRP) is removed from a patient’s blood and then re-injected back into the scalp, where its “growth factors” are said to encourage new hairs to grow. With adipose fat, it is cell-enriched tissue that is delivered to the scalp.

Not a good option for the squeamish

Injections like these are regarded by many experts in the field of hair loss as secondary treatment options that, once their safety and efficacy has been clinically-proven, may work well when used alongside currently MHRA and FDA-approved options for androgenetic alopecia. This invasive option is not well suited to the squeamish, however, though Belgravia offers a range of hair growth boosters which can are effective and non-invasive.

The only two genetic hair loss drugs that have attained this gold standard of MHRA and FDA approval to date are finasteride 1mg and minoxidil.

The one-a-day oral tablet finasteride 1mg is currently only deemed suitable for men over the age of 18 an is not prescribed for women. It works by inhibiting the formation of DHT, the testosterone-byproduct which physically causes hair thinning in cases of pattern hair loss. It binds to the follicles around the top of the scalp in genetically predisposed individuals, gradually weakening and destroying them, causing the outward signs of thinning hair, hair loss and potentially eventual baldness. Finasteride 1mg is a popular component in male pattern hair loss treatment courses at Belgravia, for men interested in preventing baldness.

Both men and women wanting to undergo treatment for female pattern hair loss can use minoxidil, as long as they are medically approved to do so and are aged 16 or over. It is a topically-applied medication that is often used by men in combination with finasteride 1mg. Belgravia clients follow treatment courses generally featuring personally recommended formulations of high strength minoxidil from the range available from the dedicated pharmacies found in our Central and City of London hair loss clinics. As with many aspects of hair loss, the precise reason this vasodilator, which opens up the potassium channels, assists with hair growth is unknown. It has, however, been hugely successful for many people, producing notable regrowth Success Stories.

These types of clinical approaches, especially when backed by the on-going support of a personal hair loss specialist and regular monitoring, can often provide significant results without the need for surgical procedures.


The Belgravia Centre Hair Loss Clinic - Hair Loss Specialist ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 19 07 17A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

With lots of new growth visible, Frederik, pictured, is happy with the way treatment is going.

Find out what he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Share this article

Autoimmune Hair Loss Research Alopecia Areata StudyScientists in Canada think they may be on the verge of being able to “supress” over-reactive cells in the body that lead to autoimmune disorders such as Alopecia Areata, which causes sudden, patchy hair loss.

According to a new report from the team at the Research Institute of the McGill University Health Centre in Montreal, regulatory T Cells – also known as Tregs (“tee-regs”) – play a key role in managing the body’s response to potential threats. When Tregs are not functioning properly, the body can “over-react” and start attacking when there is no need. This is the essence of an autoimmune disorder.

Common cause of hair loss

Alopecia Areata is the second most common cause of hair loss after androgenetic alopecia – more commonly known as male and female pattern baldness. It is estimated to affect around three per cent of people at some point during their lifetime, worldwide.

It has a number of suspected triggers, including physical trauma (such as a car accident), shock and sudden extreme stress (such as a bereavement) and long-term psychological stres, though the underlying biological mechanism that causes this form of autoimmune hair loss remains unknown. Accordingly, people who visit a specialist clinic for Alopecia Areata treatment can be frustrated as to why they are not given a precise reason as to what caused their hair loss, only what is likely to have triggered the issue.

Like all autoimmune disorders, alopecia areata is complex, and research aiming to establish more about the enigmatic condition is underway in a number of countries. Additionally, as there are currently only effective alopecia areata treatment solutions for the patchy, scalp-only variant, the medical community is highly focused on helping those with the presently untreatable, more extreme versions Alopecia Totalis and Alopecia Universalis. These cause sudden hair fall from the whole head, and from head to toe respectively. By understanding more about how autoimmune hair loss works, it is more likely that effective treatments for all severities will be discovered. For this reason, research like that of the Canadian team is vital.

Areas of the Head and Body Affected By Alopecia Areata

Areas affected by autoimmune hair loss from Alopecia Areata, Alopecia Totalis and Alopecia Universalis are shown in blue

The researchers were investigating a rare mutation in a gene called FOXP3 which they found to affect the Treg cell’s ability to dampen the immune response. This, said the study’s lead author Dr Ciriaco Piccirillo, “results in the immune system overreacting and causing inflammation. This discovery gives us key insights on how Treg cells are born and how they can be regulated.”

His colleague, Khalid Bin Dhuban, added that: “Understanding this specific mutation has allowed us to shed light on how many milder forms of chronic inflammatory diseases or autoimmune diseases could be linked to alterations in FOXP3 functions.”

Inspired by its findings, the team went on to develop a molecule that could restore the Treg cells’ ability to control the immune system for patients with the same mutation. It has now been tested in animal models, and the researchers now hope to develop new drugs that will work with other conditions where defective Treg cells are thought to be an issue.

Immune system must be protected

What’s important, of course, is that new drugs don’t take things too far and inadvertently turn off the whole immune system. As Dr Piccirillo says: “Our goal is to increase the activity of these Treg cells in certain settings, such as autoimmune diseases, but we want to turn it down in other settings, such as cancer.”

While Alopecia Areata is just such an autoimmune disorder that might benefit from the team’s work, there appears a chance that developments in Treg research may even throw some light on possible new treatment options for genetic shedding conditions such as Male Pattern Hair Loss. A recent study by the University of California, San Francisco, found that defective Tregs may also play a part in genetic thinning, too.


Circ The Belgravia Centre Hair Loss Treatment for Alopecia AreataThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

“I came for a consultation appointment on Tuesday a week ago, 13th June and was very anxious and worried about my apparent hair loss and thinning having never expected to encounter this problem, having had actually what was considered ‘lovely hair’ all my life. I found the whole experience at your clinic positive and enjoyable.
Alexandra Berkeley was very knowledgeable and efficient and put me at ease. I had already investigated all possibilities as to what was going on with my hair, so I understood all what she was saying, and although she came out with the diagnosis of female pattern hair loss (which is something I wouldn’t like to have) it wasn’t a shock to find that out and the way she presented the diagnosis and outcome was professional and well dealt with and didn’t leave me feeling hopeless. Farzana Maudhoo was very helpful in taking me through my treatment recommendations and gave me good information about the costs options available to help with this. I found everyone on the reception desk and the general atmosphere at the centre a good experience. Also Alicia – a spanish lady who did my first clinical treatment therapy was lovely and provided a very relaxing treatment and said a lot to encourage me to stop worrying. And I have to say, for the first time in ages I woke up the next day feeling happy which has continued.”

Belgravia Centre City of London Hair Loss Clinic Liverpool Street

“I had a fantastic time yesterday during my first visit at Belgravia Centre Liverpool street. Mohammed checked my hair very professionally and advised me the best possible way to recover. Very gentle and helpful person. Cherie recommend good deal and reasonable options for treatment. Excellent atmosphere. But price should be considered in future for the long-term patients. The receptionist was very friendly and welcoming to every patients in the centre. Well mannered and helpful. Very good location and easy to pop in at anytime. Clean and attractive reception and building.”

“First off I thought the customer service was fantastic, from reception all the way to the specialists. Very friendly and helpful and did not make me feel uncomfortable. I was out of my comfort zone and felt welcomed as soon as I walked in. Would highly recommend to anyone. Mohammed was polite, knowledgeable and I felt as if I was in good hands. Keep up the good work. Many thanks.”

Share this article

The Belgravia Centre Will Be Open Over the UK August Bank Holiday WeekendThis year’s Summer Bank Holiday falls on Monday 28th August so, if you’re worried that you’ve been feeling more sun on your head than usual, there’s still time to book in for your free consultation!

Both Belgravia’s Central London hair loss clinics will be open over the Bank Holiday weekend. Our flagship clinic opposite Victoria station will be open every day, while our City of London branch, just two minutes walk from Liverpool Street Station’s Broadgate exit, will be open as usual – closing on the Sunday but reopening Bank Holiday Monday. So, if you’re visiting London for the Notting Hill Carnival, it’s the perfect time to pop in en route!

Opening hours for both centres are listed below so, if you would like to arrange an appointment to see how we can help you get your hair back on track, simply call us on 020 7730 6666 or drop us a message with your preferred date, time and clinic location.

Date Clinic Opening Hours
 
Friday 25th Grosvenor Gardens (opposite Victoria Station) 9am – 6pm
New Street, City of London (opposite Liverpool St Station) (Both)
 
Saturday 26th Grosvenor Gardens 9am – 5pm
New Street, City of London (Both)
 
Sunday 27th Grosvenor Gardens 10am – 4pm
New Street, City of London CLOSED
 
Monday 28th Grosvenor Gardens 10am – 6pm
(Bank Holiday) New Street, City of London (Both)
 
Tuesday 29th Grosvenor Gardens 9am – 8pm
New Street, City of London (Both)

 


The Belgravia CentreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Multiple factors including rising levels of GDP and “an emphasis on looking good” are driving an increase in the number of people from China and India who are seeking out treatment for genetic hair loss.

According to a new report from New York-based Persistence Market Research, the Asia Pacific region as a whole is set to experience the fastest growth for products designed to treat male pattern baldness and its women’s equivalent, female pattern hair loss, in the coming years.

The report states that more than 800,000 people are seeking some kind of hair loss treatment worldwide and makes the case that: “Changing lifestyle, along with an increase in stress levels among the working class population is expected to boost the demand for treatment of hair loss globally.”

Hair Loss in China Male Pattern Baldness Treatment Asian MenStress is part of the problem

The mention of stress as being part of the problem refers in this instance to the accepted wisdom that stress is a known accelerator of androgenetic alopecia in men and women who are genetically predestined to lose hair in this way. While it is unclear by exactly how much stress can speed up shedding, many experts believe that latent genetic hair loss can begin sooner than it may have otherwise when a stressful lifestyle is a factor.

In one report, stress as an accelerator of male pattern hair loss was thought to be especially problematic in India, where a study of 1,000 men with hair loss who were aged between 25 and 35 found that more than 80 per cent of them also had hypertension. The study, which took place in Bangalore, made the assertion that large numbers of stressed-out city workers (Bangalore is a progressive, high-profile city which has been named “India’s Silicon Valley”) were losing their hair.

In addition to this, local newspaper The Bangalore Mirror stated in a separate story that around 20 per cent of the city’s women were reporting thinning hair before they were 30. Doctors said they noticed that the trend was most commonly seen amongst women with stressful lifestyles.

The American report says that demand for hair loss products in India and the wider Asia region is being driven by multiple factors as well as stress levels, including a rise in geriatric populations, increasing disposable incomes, an emphasis on looking good, and also technological advances in treatment options.

Products for hair loss

These include clinically-proven products that have been licensed by the MHRA in the UK and cleared by the FDA in the US for treatment on male pattern hair loss (one of the products, minoxidil, can also be used on women).

Belgravia Centre Hair Loss Treatment Men Women Hair Growth Hair Care 360pxBelgravia hair loss treatment clients are based all over the world, not just in the UK, as we are able to send our products by mail or courier where this is permitted. Whilst we cannot send treatments to India at present, we are able to treat clients based in China. After completing an online consultation form and receiving their diagnosis, tailored hair loss treatment courses are recommended. These often comprise advisable formulations of high strength minoxidil, and, where appropriate, the oral men-only tablet finasteride 1mg.

Further products known as hair growth boosters which are designed to maximise the chances of regrowth, may also be suggested to use alongside the hair loss drugs. These include an exclusive gender-specific hair growth supplement named Hair Vitalics, which contains key nutrients needed for men and for women to helps ensure the scalp receives highly-targeted, hair-friendly nutritional support. Additionally, clients are offered the HairMax LaserComb, an FDA-cleared device which stimulates the follicles. A choice of a laser comb or a 12 month supply of Hair Vitalics can often be included free of charge when purchasing a full Belgravia treatment course.

As a general rule, the Asian hair type is not quite so prone to genetic thinning as western hair, but that still leaves many millions of men and women affected. In fact, the new data from the US suggests that in China 21 per cent of men have genetic hair loss, while the figure for women is six per cent.


The Belgravia Centre Hair Loss Clinic - Hair Loss Specialist ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 17 07 17A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Richard, pictured, is thrilled with his regrowth to date, saying “Everyone says I’ve had my hair dyed!”

Find out what else he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 

 

 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Share this article